Imugene (ASX:IMU) confirms “favourable” survival outcome in HER-Vaxx phase two trial
Imugene (IMU) reports positive and “favourable” survival outcome in final data from…
Mon, 27 Jun | Last | Change |
2:59pm | 6,708.6 | 130 |
Currently Trading at Mon, 27 Jun 3:00pm |
S&P/ASX Sm. Ords. | 2,761.9 | 62.6 | 2.32% |
All Ordinaries | 6,897.2 | 135 | 1.99% |
S&P/ASX 100 | 5,616.9 | 107 | 1.94% |
BEX | BIKEEXCHANGE LIMITED | 6.9¢ | 97.1% |
WIN | WIDGIE NICKEL LIMITED | 35.3¢ | 43.9% |
KNI | KUNIKO LIMITED | 80.0¢ | 40.4% |
BIR | BIR FINANCIAL LIMITED | 2.0¢ | 33.3% |
EVN | EVOLUTION MINING LIMITED | $2.68 | 20.9% |
AN1 | ANAGENICS LIMITED | 1.9¢ | 20.8% |